Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
7.25
+1.10 (17.89%)
At close: Nov 13, 2026, 4:00 PM EST
7.11
-0.14 (-1.93%)
Pre-market: Nov 16, 2026, 7:15 AM EST
Orchestra BioMed Holdings Revenue
Orchestra BioMed Holdings had revenue of $91.00K in the quarter ending September 30, 2026, a decrease of -89.43%. This brings the company's total for the last twelve months to $31.21M, up 1,007.38% year-over-year. In the year 2025, Orchestra BioMed Holdings had annual revenue of $33.48M with 1,169.22% growth. That makes Orchestra BioMed Holdings the 31,133rd largest company in the world by revenue and 4,103rd in the United States.
Revenue (ttm)
$31.21M
Revenue Growth
+1,007.38%
P/S Ratio
18.29
Revenue / Employee
$362,860
Employees
86
Market Cap
570.61M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.48M | 30.84M | 1,169.22% |
| Dec 31, 2024 | 2.64M | -122.00K | -4.42% |
| Dec 31, 2023 | 2.76M | -773.00K | -21.88% |
| Dec 31, 2022 | 3.53M | 4.32M | - |
| Dec 31, 2021 | -782.00K | -6.49M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Valneva SE | 163.30M |
| Zevra Therapeutics | 147.76M |
| Wave Life Sciences | 70.92M |
| Crescent Biopharma | 15.00M |
| Capricor Therapeutics | 11.13M |
| Surrozen | 10.53M |
| Entera Bio | 42.00K |
OBIO News
- 2 days ago - Orchestra BioMed price target raised to $12 from $10 at H.C. Wainwright - TheFly
- 3 days ago - Orchestra BioMed price target raised to $12 from $10 at BTIG - TheFly
- 3 days ago - Orchestra BioMed Holdings Transcript: R&D Day 2026 - Transcripts
- 5 days ago - Orchestra BioMed reports Q3 EPS (30c), consensus (40c) - TheFly
- 5 days ago - Orchestra BioMed Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
- 6 days ago - Orchestra BioMed Holdings Quarterly report: Q3 2026 - Filings
- 6 days ago - Orchestra BioMed Holdings Earnings release: Q3 2026 - Filings
- 10 days ago - Orchestra BioMed Announces Pricing of Public Offering - GlobeNewsWire